Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
Halm
Ulrich
U
D000230:Adenocarcinoma / Q000097:blood* / Q000601:surgery; D001663:Bilirubin / Q000097:blood; D018395:CA-19-9 Antigen / Q000097:blood*; D006801:Humans; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000601:surgery; D019990:Perioperative Care; D011379:Prognosis
D018395:CA-19-9 Antigen; D001663:Bilirubin